2Garweg JG,Wenzel A.Diabitic maculopathy and retinopathy.Functional and sociomedical significance[J].Ophthalmologe,2010,107:628-635.
3Mc Intosh RL,Rogers SL,Lim L,et al.Natural history of central vein occlusion:an evidence-based systematic review[J].Ophthalmology,2010,117(6):1113-1123.
4Brown DM,Cam Dochiaro PA,Bhisitkul RB,et al.Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion:12-month outcomes of a phaseⅢstudy[J].Ophthalmology,2011,118:1594-1602.
5Campochiaro PA,Heier JS,Feiner L,et al.Ranibizumab for macular edema following branch retinal vein occlusion:six-month primary end point results of a phaseⅢstudy[J].Ophthalmology,2010,117:1102-1112.
6Matsumoto Y,Freund KB,Peiretti E,et al.Rebound macular edema following bevacizumab(Avastin)therapy for retinal venous occlusive disease[J].Retina,2007,27:426-431.
4Lang GE,Berta A,Eldem BM,et a1.Two-year safety and efficacy outcome of ranibizumab 0.5 mg in patients with visual impairment due to diabetic macular edema(DME):an interim analysis of the REs T0RE extension study[J].Ophthalmology,2013,120(10):2004-2012.
5Elman MJ,Bressler NM,Qin H,et a1.Expanded 2-year follow up of ranibizumah plus prompt or defered laser or triamcinolone plus prompt laser for diabetic macular edema[J].Ophthalmology,2011,118(4):609-614.
6Diabetic Retinopathy Clinical Research Network,Googe J,Brucker AJ,et al.Randomized trial evaluating shortterm effects of intravitrea1 ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation[J].Retina,2011,31(6):1009-1027.
